Reaffirming NIH’s Commitment to Scientific Integrity

October 21, 2024

Ensuring that the research the NIH funds and conducts adheres to the highest standards of scientific integrity, public accountability, and transparency is essential to earning the public’s trust. As such, we are pleased to announce that NIH is reaffirming its commitment to these principles by publishing its Scientific Integrity Policy.

FDA-NIH Want Your Input on a New Resource for Terminology in Clinical Research

May 7, 2024

To avoid the pitfalls that inconsistent use of terms can lead to, NIH and FDA developed a glossary of terms related to clinical research that could be used to assist the research community in effectively communicating about clinical trials. NIH and FDA are most interested in hearing community feedback on the utility of the glossary in its goal of promoting effective communications. Comments will be accepted until June 24, 2024.

Gearing Up for 2023 Part II: Implementing the NIH Data Management and Sharing Policy

May 12, 2022

I should note that when we started to receive comments on what was to become the NIH DMS Policy, one thing in particular stood out to us. Many commentors told us it would be helpful to have clear information on how to protect the privacy and respect the autonomy of participants when sharing data. Now, we all know that cliffhangers build anticipation, so without further delay, I want to share with you some of the tools NIH has been working on to answer that call.

Refreshing NIH’s Genomic Data Sharing Policy

December 3, 2021

NIH released a “Request for Information on Proposed Updates and Long-Term Considerations for the NIH Genomic Data Sharing (GDS) Policy.”  This is your opportunity to help us shape the future of the GDS Policy.  Stakeholder input is the key to ensuring that NIH strikes the right balance when updating the GDS Policy.  Comments will be accepted until February 28, 2022.